• Study Comparing Luspatercept and Epoetin Alfa for Treating Anemia in Patients with Low-Risk Myelodysplastic Syndrome Who Are Not Dependent on Blood Transfusions

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia France Germany Greece Hungary Italy +2
  • Study on the Effectiveness of Weekly IcoSema (Insulin Icodec and Semaglutide) vs. Daily Insulin Glargine for Adults with Type 2 Diabetes Not Controlled by Oral Drugs

    Not recruiting

    3 1 1 1
    Greece Italy Poland
  • Study of Apalutamide and Androgen Deprivation Therapy for Patients with High-Risk Prostate Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    Czechia France Germany Italy The Netherlands Poland +1
  • Study of Atezolizumab, Bevacizumab, and Tiragolumab for Patients with Untreated Advanced or Metastatic Liver Cancer

    Not recruiting

    3 1 1
    Belgium France Germany Italy Poland Spain
  • Study on Reduced Antiplatelet Therapy with Acetylsalicylic Acid and Clopidogrel for Patients with Coronary Artery Disease After Stent Implantation

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium France Spain
  • Study on ARGX-117 for Improving Kidney Function in Patients with Delayed Graft Function After Deceased Donor Transplant

    Not recruiting

    2 1
    Investigated Drugs:
    Austria Belgium France Italy Portugal Spain +1
  • Study of RVT-3101 for Treating Moderate to Severe Crohn’s Disease in Patients

    Not recruiting

    2 1 1
    Investigated Drugs:
    Belgium Bulgaria Czechia France Germany Hungary +5
  • Study on Upadacitinib for Adults and Adolescents with Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia Czechia Finland +12
  • Study on Spesolimab for Treating Recurrent Flares in Patients with Generalized Pustular Psoriasis

    Not recruiting

    3 1 1
    Investigated Drugs:
    Belgium France Germany Italy Spain
  • Study on the Safety and Effects of Favezelimab and Pembrolizumab for Patients with Blood Cancers

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Greece Hungary Italy

powered by